For: | Liverani E, Scaioli E, Digby RJ, Bellanova M, Belluzzi A. How to predict clinical relapse in inflammatory bowel disease patients. World J Gastroenterol 2016; 22(3): 1017-1033 [PMID: 26811644 DOI: 10.3748/wjg.v22.i3.1017] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i3/1017.htm |
Number | Citing Articles |
1 |
Mario C. Manresa, Cormac T. Taylor. Hypoxia Inducible Factor (HIF) Hydroxylases as Regulators of Intestinal Epithelial Barrier Function. Cellular and Molecular Gastroenterology and Hepatology 2017; 3(3): 303 doi: 10.1016/j.jcmgh.2017.02.004
|
2 |
E. van Lingen, M. E. Tushuizen, M. E. J. Steenhuis, T. van Deynen, J. Martens, D. Diaz-Infante Morales, A. E. van der Meulen-de Jong, I. Molendijk, S. van der Marel, P. W. J. Maljaars. Disease activity in inflammatory bowel disease patients is associated with increased liver fat content and liver fibrosis during follow-up. International Journal of Colorectal Disease 2022; 37(2): 349 doi: 10.1007/s00384-021-04065-8
|
3 |
Hiroshi Nakase, Motohiro Esaki, Fumihito Hirai, Taku Kobayashi, Katsuyoshi Matsuoka, Minoru Matsuura, Makoto Naganuma, Masayuki Saruta, Kiichiro Tsuchiya, Motoi Uchino, Kenji Watanabe, Tadakazu Hisamatsu, Akira Andoh, Shigeki Bamba, Motohiro Esaki, Mikihiro Fujiya, Kitaro Futami, Keisuke Hata, Fumihito Hirai, Sakiko Hiraoka, Tadakazu Hisamatsu, Ryota Hokari, Shunji Ishihara, Soichiro Ishihara, Michio Itabashi, Yoichi Kakuta, Jun Kato, Shingo Kato, Takehiko Katsurada, Kazuya Kitamura, Kiyonori Kobayashi, Taku Kobayashi, Kazutaka Koganei, Atsuo Maemoto, Toshiyuki Matsui, Takayuki Matsumoto, Katsuyoshi Matsuoka, Minoru Matsuura, Satoshi Motoya, Masakazu Nagahori, Makoto Naganuma, Yuji Naito, Shiro Nakamura, Hiroshi Nakase, Haruhiko Ogata, Kazuichi Okazaki, Hirotake Sakuraba, Masayuki Saruta, Shinichiro Shinzaki, Ken Sugimoto, Akira Sugita, Yasuo Suzuki, Kenichi Takahashi, Tomohisa Takagi, Kento Takenaka, Ken Takeuchi, Kiichiro Tsuchiya, Tomoyuki Tsujikawa, Motoi Uchino, Fumiaki Ueno, Kenji Watanabe, Mamoru Watanabe, Takayuki Yamamoto, Kaoru Yokoyama, Atsushi Yoshida, Naoki Yoshimura. Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021. Journal of Gastroenterology 2023; 58(4): 313 doi: 10.1007/s00535-023-01958-z
|
4 |
Bandik Föh, Torsten Schröder, Henrik Oster, Stefanie Derer, Christian Sina. Seasonal Clock Changes Are Underappreciated Health Risks—Also in IBD?. Frontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00103
|
5 |
Muhammed Bahaddin Durak, Cem Simsek, Bayram İnan, Ilhami Yuksel. Ileocecal valve that cannot be intubated in Crohn’s disease: is this a sign of poor prognosis?. International Journal of Colorectal Disease 2023; 38(1) doi: 10.1007/s00384-023-04401-0
|
6 |
Rodrigo de Oliveira Formiga, Edvaldo Balbino Alves Júnior, Roseane Carvalho Vasconcelos, Gerlane Coelho Bernardo Guerra, Aurigena Antunes de Araújo, Thaís Gomes de Carvalho, Vinícius Barreto Garcia, Raimundo Fernandes de Araújo Junior, Francisco Allysson Assis Ferreira Gadelha, Giciane Carvalho Vieira, Marianna Vieira Sobral, José Maria Barbosa Filho, Fernando Spiller, Leônia Maria Batista. p-Cymene and Rosmarinic Acid Ameliorate TNBS-Induced Intestinal Inflammation Upkeeping ZO-1 and MUC-2: Role of Antioxidant System and Immunomodulation. International Journal of Molecular Sciences 2020; 21(16): 5870 doi: 10.3390/ijms21165870
|
7 |
Yuta Fujiki, Takahisa Tanaka, Kyosuke Yakabe, Natsumi Seki, Masahiro Akiyama, Ken Uchida, Yun-Gi Kim. Hydrogen gas and the gut microbiota are potential biomarkers for the development of experimental colitis in mice. Gut Microbiome 2024; 5 doi: 10.1017/gmb.2023.17
|
8 |
Eleonora Scaioli, Andrea Belluzzi, Luigi Ricciardiello, Daniele Del Rio, Enrica Rotondo, Pedro Mena, Eleonora Derlindati, Francesca Danesi. Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial. Trials 2019; 20(1) doi: 10.1186/s13063-019-3321-8
|
9 |
Amrinder Singh, Christopher G. Fenton, Endre Anderssen, Ruth H. Paulssen. Identifying predictive signalling networks for Vedolizumab response in ulcerative colitis. International Journal of Colorectal Disease 2022; 37(6): 1321 doi: 10.1007/s00384-022-04176-w
|
10 |
Ana Mendes-Frias, Marta Moreira, Maria C. Vieira, Joana Gaifem, Patrício Costa, Luís Lopes, Ricardo Silvestre. Akkermansia muciniphila and Parabacteroides distasonis as prognostic markers for relapse in ulcerative colitis patients. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1367998
|
11 |
Kelcie Witges, Kathryn Sexton, Lesley A Graff, Laura E Targownik, Lisa M Lix, Clove Haviva, James Stone, Leigh Anne Shafer, Kathy Vagianos, Charles N Bernstein. What Is a Flare? The Manitoba Living With IBD Study. Inflammatory Bowel Diseases 2022; 28(6): 862 doi: 10.1093/ibd/izab192
|
12 |
Xiaoyi Zhang, Claudia Ramos-Rivers, Krishnapriya Prathapan, Xianling Wang, Gong Tang, Sandra Kim, David G. Binion. Peripheral Blood Monocytosis Is Associated With Long-Term Disease Severity in Pediatric-Onset Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition 2023; 76(6): 756 doi: 10.1097/MPG.0000000000003755
|
13 |
Nurul Nadirah Razali, Raja Affendi Raja Ali, Khairul Najmi Muhammad Nawawi, Azyani Yahaya, Norfilza M. Mokhtar. Targeted Sequencing of Cytokine-Induced PI3K-Related Genes in Ulcerative Colitis, Colorectal Cancer and Colitis-Associated Cancer. International Journal of Molecular Sciences 2022; 23(19): 11472 doi: 10.3390/ijms231911472
|
14 |
Florent Clerc, Mislav Novokmet, Viktoria Dotz, Karli R. Reiding, Noortje de Haan, Guinevere S.M. Kammeijer, Hans Dalebout, Marco R. Bladergroen, Frano Vukovic, Erdmann Rapp, Stephan R. Targan, Gildardo Barron, Natalia Manetti, Anna Latiano, Dermot P.B. McGovern, Vito Annese, Gordan Lauc, Manfred Wuhrer, Jack Satsangi, Elaine R. Nimmo, Nicholas T. Ventham, Hazel Drummond, Rahul Kalla, Alex T. Adams, Kate O'Leary, Ray Boyapati, David C. Wilson, Victoria Merrick, Harry Campbell, Evropi Theodoratou, Igor Rudan, Nicholas A. Kennedy, Daryl L. Fernandes, Daniel I.R. Spencer, Richard A. Gardner, Archana Shubhakar, Paulina A. Urbanowicz, Irena Trbojević-Akmačić, Jasminka Krištić, Jerko Štambuk, Maja Pučić-Baković, Marija Vilaj, Marija Pezer, Genadij Razdorov, Mirna Šimurina, Olga Gornik, Giuseppe Biscaglia, Orazio Palmieri, Fabrizio Bossa, Renata D'incà, Silvio Danese, Anna Kohn, Iain K. Pemberton, Daniel Kolarich, Vlatka Zoldos, Yurii Aulchenko, Marieke Pierik, Daisy Jonkers, Tim van den Heuvel. Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases. Gastroenterology 2018; 155(3): 829 doi: 10.1053/j.gastro.2018.05.030
|
15 |
Trilokesh D. Kidambi, Yu Liang, Pejman Motarjem, Rizvan Mirza, Alice Han, Marjorie Hein, Dupinder Singh, James L. Lin, Cornelia Banciu-Odell, Robert Toroussian, Michael W. Lew, Saro Manoukian. Episodic, severe abdominal pain due to isolated jejunal Crohn’s disease. Clinical Journal of Gastroenterology 2021; 14(4): 1084 doi: 10.1007/s12328-021-01421-7
|
16 |
Tzipi Braun, Ayelet Di Segni, Marina BenShoshan, Sandra Neuman, Nina Levhar, Michael Bubis, Orit Picard, Katya Sosnovski, Gilat Efroni, Sarit Farage Barhom, Efrat Glick Saar, Avishay Lahad, Batia Weiss, Doron Yablecovitch, Adi Lahat, Rami Eliakim, Uri Kopylov, Shomron Ben-Horin, Yael Haberman. Individualized Dynamics in the Gut Microbiota Precede Crohn's Disease Flares. American Journal of Gastroenterology 2019; 114(7): 1142 doi: 10.14309/ajg.0000000000000136
|
17 |
Aleksandra Glapa-Nowak, Mariusz Szczepanik, Jarosław Kwiecień, Anna Szaflarska-Popławska, Anna Flak-Wancerz, Barbara Iwańczak, Marcin Osiecki, Jarosław Kierkuś, Tomasz Pytrus, Dariusz Lebensztejn, Tomasz Banasiewicz, Aleksandra Banaszkiewicz, Jarosław Walkowiak. Insolation and Disease Severity in Paediatric Inflammatory Bowel Disease—A Multi-Centre Cross-Sectional Study. Journal of Clinical Medicine 2020; 9(12): 3957 doi: 10.3390/jcm9123957
|
18 |
Nicolas Pierre, Dominique Baiwir, Vân Anh Huynh-Thu, Gabriel Mazzucchelli, Nicolas Smargiasso, Edwin De Pauw, Yoram Bouhnik, David Laharie, Jean-Frédéric Colombel, Marie-Alice Meuwis, Edouard Louis. Discovery of biomarker candidates associated with the risk of short-term and mid/long-term relapse after infliximab withdrawal in Crohn’s patients: a proteomics-based study. Gut 2021; 70(8): 1450 doi: 10.1136/gutjnl-2020-322100
|
19 |
Huaijun Wang, Jose G. Vilches-Moure, Thierry Bettinger, Samir Cherkaoui, Amelie Lutz, Ramasamy Paulmurugan. Contrast Enhanced Ultrasound Molecular Imaging of Spontaneous Chronic Inflammatory Bowel Disease in an Interleukin-2 Receptor α−/− Transgenic Mouse Model Using Targeted Microbubbles. Nanomaterials 2022; 12(2): 280 doi: 10.3390/nano12020280
|
20 |
Bhawna Diwan, Rohit Sharma. Green tea EGCG effectively alleviates experimental colitis in middle-aged male mice by attenuating multiple aspects of oxi-inflammatory stress and cell cycle deregulation. Biogerontology 2022; 23(6): 789 doi: 10.1007/s10522-022-09976-9
|
21 |
Sheng Zhong, Jane Zhang, Jenny Jiao, Hongjian Zhu, Yunzhao Xing, Li Wang. A machine learning case study to predict rare clinical event of interest: imbalanced data, interpretability, and practical considerations. Journal of Biopharmaceutical Statistics 2024; : 1 doi: 10.1080/10543406.2024.2364722
|
22 |
Jael Miranda, Jennifer C. Brazil, Aaron H. Morris, Charles A. Parkos, Miguel Quiros, Asma Nusrat. Maresin-2 promotes mucosal repair and has therapeutic potential when encapsulated in thermostable nanoparticles. Proceedings of the National Academy of Sciences 2023; 120(4) doi: 10.1073/pnas.2218162120
|
23 |
Shimpei Ariki, Sotaro Ozaka, Nozomi Sachi, Thanyakorn Chalalai, Yasuhiro Soga, Chiaki Fukuda, Yomei Kagoshima, Supanuch Ekronarongchai, Kazuhiro Mizukami, Naganori Kamiyama, Kazunari Murakami, Takashi Kobayashi. GM‐CSF‐producing CCR2+CCR6+ Th17 cells are pathogenic in dextran sodium sulfate‐induced colitis model in mice. Genes to Cells 2023; 28(4): 267 doi: 10.1111/gtc.13008
|
24 |
Seung Yong Shin, Hee Sung Kim, Kisung Kim, Chang Won Choi, Jung Min Moon, Jeong Wook Kim, Hyun Jin Joo, Jeongkuk Seo, Muhyeon Sung, Chang Hwan Choi. Histologic features and predicting prognosis in ulcerative colitis patients with mild endoscopic activity. The Korean Journal of Internal Medicine 2024; 39(1): 68 doi: 10.3904/kjim.2023.167
|
25 |
Eun Sil Kim, Yiyoung Kwon, Yon Ho Choe, Mi Jin Kim. Albumin-to-Globulin Ratio at 1 Year after Anti-Tumor Necrosis Factor α Therapy Can Serve as a Prognostic Biomarker in Pediatric Crohn’s Disease Patients. Gut and Liver 2022; 16(1): 71 doi: 10.5009/gnl20322
|
26 |
Ada Adriano, Dean M. Thompson, Christel McMullan, Malcolm Price, David Moore, Lesley Booth, Jonathan Mathers. Peer support for carers and patients with inflammatory bowel disease: a systematic review. Systematic Reviews 2022; 11(1) doi: 10.1186/s13643-022-02064-6
|
27 |
Jodie Green, Aarti Kathrani. Incidence of relapse of inflammatory protein‐losing enteropathy in dogs and associated risk factors. Journal of Veterinary Internal Medicine 2022; 36(6): 1981 doi: 10.1111/jvim.16561
|
28 |
Thomas Chateau, Laurent Peyrin‐Biroulet. Evolving therapeutic goals in Crohn's disease management. United European Gastroenterology Journal 2020; 8(2): 133 doi: 10.1177/2050640619887316
|
29 |
Panupong Hansrivijit, Max M. Puthenpura, Charat Thongprayoon, Himmat S. Brar, Tarun Bathini, Karthik Kovvuru, Swetha R. Kanduri, Karn Wijarnpreecha, Wisit Cheungpasitporn. Incidence and Impacts of Inflammatory Bowel Diseases among Kidney Transplant Recipients: A Meta-Analysis. Medical Sciences 2020; 8(3): 39 doi: 10.3390/medsci8030039
|
30 |
Alyce Anderson, Cynthia Cherfane, Benjamin Click, Claudia Ramos-Rivers, Ioannis E Koutroubakis, Jana G Hashash, Dmitriy Babichenko, Gong Tang, Michael Dunn, Arthur Barrie, Siobhan Proksell, Jeffrey Dueker, Elyse Johnston, Marc Schwartz, David G Binion. Monocytosis Is a Biomarker of Severity in Inflammatory Bowel Disease: Analysis of a 6-Year Prospective Natural History Registry. Inflammatory Bowel Diseases 2022; 28(1): 70 doi: 10.1093/ibd/izab031
|
31 |
Beatrice Kölbel, Stefanie Hamacher, Martin Hellmich, Wolfgang Kruis. Low Dietary Flavonoid Consumption Is Associated to Severe Inflammatory Bowel Disease. Gastro Hep Advances 2024; 3(1): 31 doi: 10.1016/j.gastha.2023.08.015
|
32 |
María E. Prados, Adela García-Martín, Juan D. Unciti-Broceta, Belén Palomares, Juan A. Collado, Alberto Minassi, Marco A. Calzado, Giovanni Appendino, Eduardo Muñoz. Betulinic acid hydroxamate prevents colonic inflammation and fibrosis in murine models of inflammatory bowel disease. Acta Pharmacologica Sinica 2021; 42(7): 1124 doi: 10.1038/s41401-020-0497-0
|
33 |
Choong Wui Cho, Myung-Won You, Chi Hyuk Oh, Chang Kyun Lee, Sung Kyoung Moon. Long-term Disease Course of Crohn’s Disease: Changes in Disease Location, Phenotype, Activities, and Predictive Factors. Gut and Liver 2022; 16(2): 157 doi: 10.5009/gnl210118
|
34 |
Marina Moreira de Castro, Ligiana Pires Corona, Lívia Bitencourt Pascoal, Josiane Érica Miyamoto, Leticia Martins Ignacio-Souza, Maria de Lourdes Setsuko Ayrizono, Marcio Alberto Torsoni, Adriana Souza Torsoni, Raquel Franco Leal, Marciane Milanski. Dietary Patterns Associated to Clinical Aspects in Crohn’s Disease Patients. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-64024-1
|
35 |
Y. B. Uspenskaya, S. J. Belogubova. DIAGNOSTIC POSSIBILITIES OF FECAL CALPROTECTIN APPLICATION IN PATIENTS WITH INFLAMMATORY DOWEL DISEASES DURING PREGNANCY (literature review and clinical observations). Koloproktologia 2018; (2): 95 doi: 10.33878/2073-7556-2018-0-2-95-101
|
36 |
Elena Milanesi, Maria Dobre, Teodora E. Manuc, Gabriel Becheanu, Cristian G. Tieranu, Elena M. Ionescu, Mircea Manuc. Mucosal gene expression changes induced by anti‐TNF treatment in inflammatory bowel disease patients. Drug Development Research 2019; 80(6): 831 doi: 10.1002/ddr.21566
|
37 |
Ashwin N Ananthakrishnan. Microbiome-Based Biomarkers for IBD. Inflammatory Bowel Diseases 2020; 26(10): 1463 doi: 10.1093/ibd/izaa071
|
38 |
Xiuli Zuo, Tian Ma. Atlas of Endoscopy Imaging in Inflammatory Bowel Disease. 2020; : 257 doi: 10.1016/B978-0-12-814811-2.00018-9
|
39 |
Maojuan Li, Yan Tao, Yang Sun, Jing Wu, Fengrui Zhang, Yunling Wen, Min Gong, Jingxian Yan, Hao Liang, Xinyu Bai, Junkun Niu, Yinglei Miao. Constructing a prediction model of inflammatory bowel disease recurrence based on factors affecting the quality of life. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1041505
|
40 |
雨林 刘. A Review of Research on the Correlation between Intestinal Ultrasound and Ulcerative Colitis. Advances in Clinical Medicine 2024; 14(02): 4687 doi: 10.12677/ACM.2024.142648
|
41 |
Tsvetelina Veselinova Velikova, Zoya Angelova Spassova, Lyuben Mitkov Milatchkov, Dobriana Georgieva Panova, Ekaterina Ivanova Ivanova - Todorova, Kalina Dinkova Tumangelova - Yuzeir, Ekaterina Krasimirova Kurteva, Dobroslav Stanimirov Kyurkchiev, Siragan Arshavir Deredjan, Rosen Kirilov Nikolov, Iskra Petrova Altankova, Lyudmila Mateva Vladimirova. Dynamics of Some Routine Immunological Parameters During Anti - TNF Therapy in Patients with Crohn’s Disease. Annals of Colorectal Research 2018; 6(1) doi: 10.5812/acr.68674
|
42 |
Ammar Hassanzadeh Keshteli, Floris F van den Brand, Karen L Madsen, Rupasri Mandal, Rosica Valcheva, Karen I Kroeker, Beomsoo Han, Rhonda C Bell, Janis Cole, Thomas Hoevers, David S Wishart, Richard N Fedorak, Levinus A Dieleman. Dietary and metabolomic determinants of relapse in ulcerative colitis patients: A pilot prospective cohort study. World Journal of Gastroenterology 2017; 23(21): 3890-3899 doi: 10.3748/wjg.v23.i21.3890
|
43 |
Shadi Aghamohammad, Amin Sepehr, Seyedeh Tina Miri, Saeideh Najafi, Mohammad R. Pourshafie, Mahdi Rohani. Ameliorating inflammation in an in vitro model by screening the anti-inflammatory and immunomodulatory roles of putative probiotics in inflammatory bowel disease. Heliyon 2023; 9(9): e19475 doi: 10.1016/j.heliyon.2023.e19475
|
44 |
Christopher R. Shaler, Alexandra A. Parco, Wael Elhenawy, Jasmeen Dourka, Jennifer Jury, Elena F. Verdu, Brian K. Coombes. Psychological stress impairs IL22-driven protective gut mucosal immunity against colonising pathobionts. Nature Communications 2021; 12(1) doi: 10.1038/s41467-021-26992-4
|
45 |
H. J. Galipeau, E. F. Verdu. The complex task of measuring intestinal permeability in basic and clinical science. Neurogastroenterology & Motility 2016; 28(7): 957 doi: 10.1111/nmo.12871
|
46 |
Payam Jannatdoust, Parya Valizadeh, Mahshad Razaghi, Maedeh Rouzbahani, Amirbahador Abbasi, Arvin Arian. Role of abbreviated non-contrast-enhanced MR-enterography in the evaluation of Crohn's disease activity and complications as an alternative for full protocol contrast-enhanced study: A systematic review and meta-analysis. Research in Diagnostic and Interventional Imaging 2023; 6: 100030 doi: 10.1016/j.redii.2023.100030
|
47 |
Harald Engler, Sigrid Elsenbruch, Laura Rebernik, Janina Köcke, Holger Cramer, Margarita Schöls, Jost Langhorst. Stress burden and neuroendocrine regulation of cytokine production in patients with ulcerative colitis in remission. Psychoneuroendocrinology 2018; 98: 101 doi: 10.1016/j.psyneuen.2018.08.009
|
48 |
Dominika Głąbska, Dominika Guzek, Gustaw Lech. Analysis of the Nutrients and Food Products Intake of Polish Males with Ulcerative Colitis in Remission. Nutrients 2019; 11(10): 2333 doi: 10.3390/nu11102333
|
49 |
Rikke Edelbo, Malte Hjerrild, Palle Bager. Impact of remission on worries experienced by patients receiving biologic therapy for inflammatory bowel disease. Gastrointestinal Nursing 2020; 18(7): 28 doi: 10.12968/gasn.2020.18.7.28
|
50 |
Patricia Sanz Segura, Fernando Gomollón, Diego Casas, Marisa Iborra, Milagros Vela, Agnès Fernández-Clotet, Roser Muñoz, Irene García de la Filia, María García Prada, Juan Ángel Ferrer Rosique, María José García, Ruth de Francisco, Lara Arias, Jesús Barrio, Iván Guerra, Ángel Ponferrada, Javier P. Gisbert, Marta Carrillo-Palau, Xavier Calvet, Lucía Márquez-Mosquera, Beatriz Gros, Fiorella Cañete, David Monfort, Rosa Eva Madrigal Domínguez, Óscar Roncero, Viviana Laredo, Miguel Montoro, Carmen Muñoz, Beatriz López-Cauce, Rufo Lorente, Ana Fuentes Coronel, Pablo Vega, Dolores Martín, Elena Peña, Pilar Varela, Sonsoles Olivares, Ramón Pajares, Alfredo J. Lucendo, Eva Sesé, Belén Botella Mateu, Pilar Nos, Eugeni Domènech, Santiago García-López. Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort study. Digestive and Liver Disease 2024; doi: 10.1016/j.dld.2024.05.021
|
51 |
Manoj Kumar, Selvasankar Murugesan, Nazira Ibrahim, Mamoun Elawad, Souhaila Al Khodor. Predictive biomarkers for anti-TNF alpha therapy in IBD patients. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05058-1
|
52 |
Nicolas Pierre, Sophie Vieujean, Laurent Peyrin-Biroulet, Marie-Alice Meuwis, Edouard Louis. Defining Biological Remission in Crohn’s Disease: Interest, Challenges and Future Directions. Journal of Crohn's and Colitis 2023; 17(10): 1698 doi: 10.1093/ecco-jcc/jjad086
|
53 |
Masaaki Funata, Yasunori Nio, Derek M. Erion, Wendy L. Thompson, Takanori Takebe. The promise of human organoids in the digestive system. Cell Death & Differentiation 2021; 28(1): 84 doi: 10.1038/s41418-020-00661-3
|
54 |
Nikola Cousin, Sophie Bartel, Jeannette Scholl, Carlotta Tacconi, Annina Egger, Gudrun Thorhallsdottir, Dario Neri, Lothar C. Dieterich, Michael Detmar. Antibody-Mediated Delivery of VEGF-C Promotes Long-Lasting Lymphatic Expansion That Reduces Recurrent Inflammation. Cells 2022; 12(1): 172 doi: 10.3390/cells12010172
|
55 |
Dominika Głąbska, Aleksandra Kołota, Katarzyna Lachowicz, Dominika Skolmowska, Małgorzata Stachoń, Dominika Guzek. Vitamin D Supplementation and Mental Health in Inflammatory Bowel Diseases and Irritable Bowel Syndrome Patients: A Systematic Review. Nutrients 2021; 13(10): 3662 doi: 10.3390/nu13103662
|
56 |
Aaron S Bancil, Alicia M Sandall, Megan Rossi, Benoit Chassaing, James O Lindsay, Kevin Whelan. Food Additive Emulsifiers and Their Impact on Gut Microbiome, Permeability, and Inflammation: Mechanistic Insights in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2021; 15(6): 1068 doi: 10.1093/ecco-jcc/jjaa254
|
57 |
Walter Reinisch, Remo Panaccione, Peter Bossuyt, Filip Baert, Alessandro Armuzzi, Xavier Hébuterne, Simon Travis, Silvio Danese, William J Sandborn, Stefan Schreiber, Sofie Berg, Qian Zhou, Kristina Kligys, Ezequiel Neimark, Ahmed A Suleiman, Geert D’Haens, Jean-Frederic Colombel. Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn’s Disease: A Post Hoc Analysis From the CALM Study. Inflammatory Bowel Diseases 2020; 26(10): 1562 doi: 10.1093/ibd/izaa025
|
58 |
Juan Sebastian LASA, Ignacio ZUBIAURRE, Astrid RAUSCH, Pablo OLIVERA. PLACEBO USE IN THE CONTEXT OF INFLAMMATORY BOWEL DISEASE CLINICAL TRIALS. Arquivos de Gastroenterologia 2020; 57(1): 87 doi: 10.1590/s0004-2803.202000000-15
|
59 |
Rayna Shentova-Eneva, Tsvetelina Velikova. Laboratory Assessment of Disease Activity in Pediatric Patients with Inflammatory Bowel Disease: What’s New?. Gastroenterology Insights 2020; 11(2): 58 doi: 10.3390/gastroent11020009
|
60 |
Zinan Zhang, Xiaoyu Yu, Ning Fang, Xiuyan Long, Xixian Ruan, Jianing Qiu, Sifan Tao, Pan Gong, Kai Nie, An Li, Xiaoyan Wang, Li Tian. Can visceral adipose tissue and skeletal muscle predict recurrence of newly diagnosed Crohn’s disease in different treatments. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02327-5
|
61 |
Laura Musumeci, Alessandro Maugeri, Caterina Russo, Giovanni Enrico Lombardo, Santa Cirmi, Michele Navarra. Citrus Flavonoids and Autoimmune Diseases: A Systematic Review of
Clinical Studies. Current Medicinal Chemistry 2023; 30(19): 2191 doi: 10.2174/0929867329666220629144744
|
62 |
Gerard Serrano-Gómez, Luis Mayorga, Iñigo Oyarzun, Joaquim Roca, Natalia Borruel, Francesc Casellas, Encarna Varela, Marta Pozuelo, Kathleen Machiels, Francisco Guarner, Severine Vermeire, Chaysavanh Manichanh. Dysbiosis and relapse-related microbiome in inflammatory bowel disease: A shotgun metagenomic approach. Computational and Structural Biotechnology Journal 2021; 19: 6481 doi: 10.1016/j.csbj.2021.11.037
|
63 |
Sherman Picardo, Mansour Altuwaijri, Shane M. Devlin, Cynthia H. Seow. Complementary and alternative medications in the management of inflammatory bowel disease. Therapeutic Advances in Gastroenterology 2020; 13 doi: 10.1177/1756284820927550
|
64 |
Georges Tarris, Marie Estienney, Philippe Daval-Frérot, Anne-Cécile Lariotte, Damien Aubignat, Karine Sé, Christophe Michiels, Laurent Martin, Alexis de Rougemont, Gaël Belliot, Susana López. Intestinal Norovirus Binding Patterns in Nonsecretor Individuals. Journal of Virology 2022; 96(19) doi: 10.1128/jvi.00865-22
|
65 |
Kang-In Lee, Min-Soo Kim, Heung Joo Yuk, Yousang Jo, Hye Jin Kim, Jieun Kim, Hyungjun Kim, Ju-Young Shin, Donghwan Kim, Ki-Sun Park. Alleviating depressive-like behavior in DSS-induced colitis mice: Exploring naringin and poncirin from Poncirus trifoliata extracts. Biomedicine & Pharmacotherapy 2024; 175: 116770 doi: 10.1016/j.biopha.2024.116770
|
66 |
Duaa Ahmed Elhag, Manoj Kumar, Marwa Saadaoui, Anthony K. Akobeng, Fatma Al-Mudahka, Mamoun Elawad, Souhaila Al Khodor. Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response. International Journal of Molecular Sciences 2022; 23(13): 6966 doi: 10.3390/ijms23136966
|
67 |
Jin Yuan. CCR2: A characteristic chemokine receptor in normal and pathological intestine. Cytokine 2023; 169: 156292 doi: 10.1016/j.cyto.2023.156292
|
68 |
Masa Maeda, Shintaro Sagami, Moyu Tashima, Yoko Yamana, Ryo Karashima, Yusuke Miyatani, Aya Hojo, Masaru Nakano, Toshifumi Hibi, Taku Kobayashi. Milan Ultrasound Criteria Predict Relapse of Ulcerative Colitis in Remission. Inflammatory Intestinal Diseases 2023; 8(3): 95 doi: 10.1159/000532052
|
69 |
Nienke Z Borren, Damian Plichta, Amit D Joshi, Gracia Bonilla, Ruslan Sadreyev, Hera Vlamakis, Ramnik J Xavier, Ashwin N Ananthakrishnan. Multi-“-Omics” Profiling in Patients With Quiescent Inflammatory Bowel Disease Identifies Biomarkers Predicting Relapse. Inflammatory Bowel Diseases 2020; 26(10): 1524 doi: 10.1093/ibd/izaa183
|
70 |
B Lo, M K Vester-Andersen, I Vind, M Prosberg, M Dubinsky, C A Siegel, F Bendtsen, J Burisch. Changes in Disease Behaviour and Location in Patients With Crohn’s Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort. Journal of Crohn's and Colitis 2018; 12(3): 265 doi: 10.1093/ecco-jcc/jjx138
|
71 |
Maryana V. Morozova, Galina V. Kalmykova, Nadezhda I. Akulova, Yuriy V. Ites, Valentina I. Korkina, Ekaterina A. Litvinova. Autoclaved Diet with Inactivated Spores of Bacillus spp. Decreased Reproductive Performance of Muc2−/− and Muc2+/− Mice. Animals 2022; 12(18): 2399 doi: 10.3390/ani12182399
|
72 |
Michael Bramhall, Kevin Rich, Ajanta Chakraborty, Larisa Logunova, Namshik Han, James Wilson, John McLaughlin, Andy Brass, Sheena M Cruickshank. Differential Expression of Soluble Receptor for Advanced Glycation End-products in Mice Susceptible or Resistant to Chronic Colitis. Inflammatory Bowel Diseases 2020; 26(3): 360 doi: 10.1093/ibd/izz311
|
73 |
Nurul Nadirah Razali, Raja Affendi Raja Ali, Khairul Najmi Muhammad Nawawi, Azyani Yahaya, Norshafila Diana Mohd Rathi, Norfilza Mohd Mokhtar. Roles of phosphatidylinositol-3-kinases signaling pathway in inflammation-related cancer: Impact of rs10889677 variant and buparlisib in colitis-associated cancer. World Journal of Gastroenterology 2023; 29(40): 5543-5556 doi: 10.3748/wjg.v29.i40.5543
Abstract(481) |
Core Tip(526) |
Full Article(HTML)(1541)
|
Full Article with Cover (PDF)-9796K(183)
|
Full Article (Word)-3139K(51)
|
Audio-465K(12)
|
Peer-Review Report-235K(52)
|
Answering Reviewers-32K(53)
|
Full Article (PDF)-9537K(171)
|
Full Article (XML)-143K(55)
|
Times Cited (2)
|
Total Visits (6414)
|
Open
|
74 |
Yasmin Hadian, Daniel Fregoso, Chuong Nguyen, Michelle D. Bagood, Sara E. Dahle, Melanie G. Gareau, Roslyn Rivkah Isseroff. Microbiome‐skin‐brain axis: A novel paradigm for cutaneous wounds. Wound Repair and Regeneration 2020; 28(3): 282 doi: 10.1111/wrr.12800
|
75 |
Dominika Głąbska, Dominika Guzek, Karolina Gałązka, Gustaw Lech. Therapeutic Potential of Proanthocyanidins in Ulcerative Colitis in Remission. Journal of Clinical Medicine 2020; 9(3): 771 doi: 10.3390/jcm9030771
|
76 |
Mohammad Reza Lahimchi, Majid Eslami, Bahman Yousefi. Interleukin-35 and Interleukin-37 anti-inflammatory effect on inflammatory bowel disease: Application of non-coding RNAs in IBD therapy. International Immunopharmacology 2023; 117: 109932 doi: 10.1016/j.intimp.2023.109932
|
77 |
Seoyeon Kim, Byung-Hee Lee, Xiuyu Zhang, Jae-Woo Park, Sle Lee, Hyangsook Lee. Adjunctive herbal medicine therapy for inflammatory bowel disease: A systematic review and meta-analysis. European Journal of Integrative Medicine 2017; 12: 12 doi: 10.1016/j.eujim.2017.03.009
|
78 |
Jean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, Milan Lukas, Filip Baert, Tomas Vaňásek, Ahmet Danalioglu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hébuterne, Simon Travis, Silvio Danese, Walter Reinisch, William J Sandborn, Paul Rutgeerts, Daniel Hommes, Stefan Schreiber, Ezequiel Neimark, Bidan Huang, Qian Zhou, Paloma Mendez, Joel Petersson, Kori Wallace, Anne M Robinson, Roopal B Thakkar, Geert D'Haens. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial. The Lancet 2017; 390(10114): 2779 doi: 10.1016/S0140-6736(17)32641-7
|
79 |
Mohamed Saleh Ismail, Diane E Peters, Steven P Rowe, Ali Salavati, Sowmya Sharma, Robert Anders, Martin Pomper, Barbara S Slusher, Florin M Selaru. PSMA-Targeted PET Radiotracer [18F]DCFPyL as an Imaging Biomarker in Inflammatory Bowel Disease. Clinical and Experimental Gastroenterology 2023; : 237 doi: 10.2147/CEG.S404009
|
80 |
Dominika Skolmowska, Dominika Głąbska, Dominika Guzek, Gustaw Lech. Association between Dietary Isoflavone Intake and Ulcerative Colitis Symptoms in Polish Caucasian Individuals. Nutrients 2019; 11(8): 1936 doi: 10.3390/nu11081936
|
81 |
Satoshi Hiyama, Hideki Iijima, Syoichiro Kawai, Akira Mukai, Eri Shiraishi, Shuko Iwatani, Toshio Yamaguchi, Manabu Araki, Yoshito Hayashi, Shinichiro Shinzaki, Tsunekazu Mizushima, Masahiko Tsujii, Tetsuo Takehara. Narrow-band imaging with magnifying endoscopy for Peyer's patches is useful in predicting the recurrence of remissive patients with ulcerative colitis. Intestinal Research 2016; 14(4): 314 doi: 10.5217/ir.2016.14.4.314
|
82 |
Kendra Kamp, Gwen Wyatt, Sharon Dudley-Brown, Kelly Brittain, Barbara Given. Using cognitive interviewing to improve questionnaires: An exemplar study focusing on individual and condition-specific factors. Applied Nursing Research 2018; 43: 121 doi: 10.1016/j.apnr.2018.06.007
|
83 |
Badrinath Jagannath, Kai-Chun Lin, Madhavi Pali, Devang Sankhala, Sriram Muthukumar, Shalini Prasad. A Sweat-based Wearable Enabling Technology for Real-time Monitoring of IL-1β and CRP as Potential Markers for Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2020; 26(10): 1533 doi: 10.1093/ibd/izaa191
|
84 |
Cristiana Popp, Radu Bogdan Mateescu. New Concepts in Inflammatory Bowel Disease. 2018; doi: 10.5772/intechopen.72893
|
85 |
Naïm Ouldali, Jean-Pierre Hugot, Jérôme Viala, Mohamed Damir, Christine Martinez-Vinson, Ulrich Meinzer. Early Arthritis Is Associated With Failure of Immunosuppressive Drugs and Severe Pediatric Crohn’s Disease Evolution. Inflammatory Bowel Diseases 2018; 24(11): 2423 doi: 10.1093/ibd/izy137
|
86 |
Ahmad Albshesh, Alon Abend, Reuma Margalit Yehuda, Hussein Mahajna, Bella Ungar, Shomron Ben-Horin, Uri Kopylov, Dan Carter. Intestinal ultrasound accurately predicts future therapy failure in Crohn’s disease patients in a biologics-induced remission. European Journal of Gastroenterology & Hepatology 2024; doi: 10.1097/MEG.0000000000002883
|
87 |
Karin Amcoff, Yang Cao, Yaroslava Zhulina, Maria Lampinen, Jonas Halfvarson, Marie Carlson. Prognostic significance of faecal eosinophil granule proteins in inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2019; 54(10): 1237 doi: 10.1080/00365521.2019.1670251
|
88 |
Doron Yablecovitch, Uri Kopylov, Adi Lahat, Michal M. Amitai, Eyal Klang, Dana Ben-Ami Shor, Sandra Neuman, Nina Levhar, Ella Fudim, Benjamin Avidan, Ido Laish, Limor Selinger, Noam Zingboim-Orbach, Orit Picard, Miri Yavzori, Rami Eliakim, Shomron Ben-Horin. Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn’s disease, a post hoc analysis. Therapeutic Advances in Gastroenterology 2019; 12 doi: 10.1177/1756284819881590
|
89 |
Giada Amodeo, Silvia Franchi, Giulia Galimberti, Benedetta Riboldi, Paola Sacerdote. The Prokineticin System in Inflammatory Bowel Diseases: A Clinical and Preclinical Overview. Biomedicines 2023; 11(11): 2985 doi: 10.3390/biomedicines11112985
|
90 |
Elena Vegni, Daniela Gilardi, Stefanos Bonovas, Bianca E Corrò, Julia Menichetti, Daniela Leone, Allocca Mariangela, Federica Furfaro, Silvio Danese, Gionata Fiorino. Illness Perception in Inflammatory Bowel Disease Patients is Different Between Patients With Active Disease or in Remission: A Prospective Cohort Study. Journal of Crohn's and Colitis 2019; 13(4): 417 doi: 10.1093/ecco-jcc/jjy183
|
91 |
Murat Cakir, Elif Sag, Guzide Dogan, Fatih Unal, Erhun Kasirga. Clinical significance of low transaminase levels in children with inflammatory bowel disease. World Journal of Pediatrics 2019; 15(2): 143 doi: 10.1007/s12519-019-00235-5
|
92 |
David Fenton, Natalie K Choi, Nicole M Garcia, Emma C Dyer, Nathaniel A Cohen, David T Rubin. Factors Associated With Fecal Calprotectin Sample Collection Compliance: An IBD Center Quality Improvement Project. Crohn's & Colitis 360 2022; 4(4) doi: 10.1093/crocol/otac042
|
93 |
Claudia Seikrit, Judith I. Schimpf, Stephanie Wied, Eleni Stamellou, Ana Izcue, Oliver Pabst, Thomas Rauen, Kaatje Lenaerts, Jürgen Floege. Intestinal permeability in patients with IgA nephropathy and other glomerular diseases: an observational study. Journal of Nephrology 2022; 36(2): 463 doi: 10.1007/s40620-022-01454-2
|
94 |
Mahesh Gajendran, Priyadarshini Loganathan, Guillermo Jimenez, Anthony P. Catinella, Nathaniel Ng, Chandraprakash Umapathy, Nathalie Ziade, Jana G. Hashash. A comprehensive review and update on ulcerative colitis,. Disease-a-Month 2019; 65(12): 100851 doi: 10.1016/j.disamonth.2019.02.004
|
95 |
Kelly C Cushing, Richard Mclean, Keely G McDonald, Jenny K Gustafsson, Kathryn A Knoop, Devesha H Kulkarni, R Balfour Sartor, Rodney D Newberry. Predicting Risk of Postoperative Disease Recurrence in Crohn’s Disease: Patients With Indolent Crohn’s Disease Have Distinct Whole Transcriptome Profiles at the Time of First Surgery. Inflammatory Bowel Diseases 2019; 25(1): 180 doi: 10.1093/ibd/izy228
|